Author: Oregon Liquor Control Commission. Temperance and Rehabilitation Division
Publisher:
ISBN:
Category : Alcoholism
Languages : en
Pages : 6

View

Book Description

Author: Oregon State Library
Publisher:
ISBN:
Category : Oregon
Languages : en
Pages : 616

View

Book Description

Author: University of California, Berkeley. Institute of Governmental Studies. Library
Publisher:
ISBN:
Category : Political science
Languages : en
Pages : 868

View

Book Description

Author: North American Association of Alcoholism Programs
Publisher:
ISBN:
Category : Alcoholism
Languages : en
Pages : 86

View

Book Description

Author: University of California, Berkeley. Institute of Governmental Studies
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 868

View

Book Description

Author: Association for the Advancement of Instruction about Alcohol and Narcotics
Publisher:
ISBN:
Category : Alcoholism
Languages : en
Pages : 280

View

Book Description

Author:
Publisher:
ISBN:
Category : Education
Languages : en
Pages : 1536

View

Book Description

Author:
Publisher:
ISBN:
Category : Filmstrips
Languages : en
Pages : 212

View

Book Description
Constitutes the quinquennial cumulation of the National union catalog . . . Motion pictures and filmstrips.

Author: R.R. Bowker Company
Publisher: R. R. Bowker
ISBN:
Category : Reference
Languages : en
Pages : 1436

View

Book Description

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483

View

Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.